-
Je něco špatně v tomto záznamu ?
Multipotency and therapeutic potential of NG2 cells
M. Valny, P. Honsa, J. Kriska, M. Anderova,
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, přehledy, práce podpořená grantem
- MeSH
- antigeny metabolismus MeSH
- kmenové buňky účinky léků fyziologie MeSH
- látky ovlivňující centrální nervový systém farmakologie terapeutické užití MeSH
- lidé MeSH
- mezibuněčné signální peptidy a proteiny metabolismus MeSH
- multipotentní kmenové buňky účinky léků fyziologie transplantace MeSH
- neurogeneze účinky léků fyziologie MeSH
- neuroglie účinky léků fyziologie MeSH
- neuroplasticita účinky léků fyziologie MeSH
- oligodendroglie účinky léků fyziologie MeSH
- proliferace buněk účinky léků fyziologie MeSH
- proteoglykany metabolismus MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
NG2 cells represent one of the most proliferative glial cell populations in the intact mammalian central nervous system (CNS). They are well-known for their ability to renew themselves or to generate new oligodendrocytes during development as well as in adulthood, therefore also being termed oligodendrocyte progenitor cells. Following CNS injuries, such as demyelination, trauma or ischemia, the proliferative capacity of NG2 cells rapidly increases and moreover, their differentiation potential broadens, as documented by numerous reports also describing their differentiation into astrocytes or even neurons. Here, we summarize the current knowledge about NG2 cells proliferation, their fate plasticity during embryogenesis as well as in postnatal CNS under physiological and pathological conditions, with the main emphasis on the role of various signaling molecules, growth factors, hormones or even neurotransmitters on the fate potential of NG2 cells.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18016599
- 003
- CZ-PrNML
- 005
- 20180521123356.0
- 007
- ta
- 008
- 180515s2017 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.bcp.2017.05.008 $2 doi
- 035 __
- $a (PubMed)28522408
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Valny, Martin $u Department of Cellular Neurophysiology, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
- 245 10
- $a Multipotency and therapeutic potential of NG2 cells / $c M. Valny, P. Honsa, J. Kriska, M. Anderova,
- 520 9_
- $a NG2 cells represent one of the most proliferative glial cell populations in the intact mammalian central nervous system (CNS). They are well-known for their ability to renew themselves or to generate new oligodendrocytes during development as well as in adulthood, therefore also being termed oligodendrocyte progenitor cells. Following CNS injuries, such as demyelination, trauma or ischemia, the proliferative capacity of NG2 cells rapidly increases and moreover, their differentiation potential broadens, as documented by numerous reports also describing their differentiation into astrocytes or even neurons. Here, we summarize the current knowledge about NG2 cells proliferation, their fate plasticity during embryogenesis as well as in postnatal CNS under physiological and pathological conditions, with the main emphasis on the role of various signaling molecules, growth factors, hormones or even neurotransmitters on the fate potential of NG2 cells.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antigeny $x metabolismus $7 D000941
- 650 _2
- $a proliferace buněk $x účinky léků $x fyziologie $7 D049109
- 650 _2
- $a látky ovlivňující centrální nervový systém $x farmakologie $x terapeutické užití $7 D002491
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mezibuněčné signální peptidy a proteiny $x metabolismus $7 D036341
- 650 _2
- $a multipotentní kmenové buňky $x účinky léků $x fyziologie $x transplantace $7 D039902
- 650 _2
- $a neurogeneze $x účinky léků $x fyziologie $7 D055495
- 650 _2
- $a neuroglie $x účinky léků $x fyziologie $7 D009457
- 650 _2
- $a neuroplasticita $x účinky léků $x fyziologie $7 D009473
- 650 _2
- $a oligodendroglie $x účinky léků $x fyziologie $7 D009836
- 650 _2
- $a proteoglykany $x metabolismus $7 D011509
- 650 _2
- $a kmenové buňky $x účinky léků $x fyziologie $7 D013234
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Honsa, Pavel $u Department of Cellular Neurophysiology, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
- 700 1_
- $a Kriska, Jan $u Department of Cellular Neurophysiology, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
- 700 1_
- $a Anderova, Miroslava $u Department of Cellular Neurophysiology, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague, Czech Republic. Electronic address: anderova@biomed.cas.cz.
- 773 0_
- $w MED00000704 $t Biochemical pharmacology $x 1873-2968 $g Roč. 141, č. - (2017), s. 42-55
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28522408 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180515 $b ABA008
- 991 __
- $a 20180521123538 $b ABA008
- 999 __
- $a ok $b bmc $g 1300223 $s 1013439
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 141 $c - $d 42-55 $e 20170515 $i 1873-2968 $m Biochemical pharmacology $n Biochem Pharmacol $x MED00000704
- LZP __
- $a Pubmed-20180515